The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...

Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... given the somewhat tongue-twisting brand name of Ohtuvayre – is the first ...

Avoid in chronic respiratory disease, acute febrile illness with productive cough, compromised respiratory function (eg, COPD ... Formerly known under the brand name Phenergan with Codeine.

New Mountain Capital, LLC ("New Mountain"), a leading growth-oriented investment firm with more than $55 billion in assets under management, today announced a definitive agreement to acquire Machinify ...

Costs of brand-name prescriptions have been rising for years—the average drug price is now more than $300 per month ... This ...

Costs of brand-name prescriptions have been rising for years—the average drug price is now more than $300 per month ... This is great news for people with COPD or asthma, who can now pay only $35 for ...

“Both companies are ‘houses of brands’, in other words a collection of well-diversified luxury businesses serving multiple ...

It was another turbulent year from start to end, dominated by wars still raging in Ukraine and the Middle East. But 2024 also ...

Sanofi’s SNY stock has declined 10.2% in the past three months. However, a lot of this price decline was due to the downtrend ...

Types of Inhaled Asthma Medications Within each class of inhaled asthma medication are different drugs with different brand names. Within each brand are ... Choosing the right inhaler for your asthma ...

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.